Banff, Alberta—Preliminary findings from an ongoing trial suggest that live microbes may not be necessary for fecal transplantation to be clinically effective in treating recurrent infection with Clostridioides difficile.
Three of four patients receiving lyophilized sterile fecal filtrate did not experience a recurrence of C. difficile (formerly Clostridium difficile) by week 8 of the ongoing study, compared with four of the five patients randomly assigned to lyophilized fecal microbiota